These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31412090)

  • 21. Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012-2018.
    Engler C; Leo M; Pfeifer B; Juchum M; Chen-Koenig D; Poelzl K; Schoenherr H; Vill D; Oberdanner J; Eisendle E; Middeldorf K; Heindl B; Gaenzer H; Bode G; Kirchmeyr K; Ladner G; Rieger L; Koellensperger U; Schwaiger A; Stoeckl F; Zangerl G; Lechleitner M; Delmarko I; Oberaigner W; Rissbacher C; Tilg H; Ebenbichler C
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32873600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
    Zhou JB; Tang X; Han M; Yang J; Simó R
    Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults.
    Pilla SJ; Segal JB; Alexander GC; Boyd CM; Maruthur NM
    J Am Geriatr Soc; 2019 May; 67(5):1066-1073. PubMed ID: 30703251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of the development of metformin and sulfonylurea prescriptions in the Czech Republic].
    Janíčková-Žďarská D; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S25-9. PubMed ID: 26652962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of antidiabetic drugs in the U.S., 2003-2012.
    Hampp C; Borders-Hemphill V; Moeny DG; Wysowski DK
    Diabetes Care; 2014; 37(5):1367-74. PubMed ID: 24623020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.
    Ikonomidis I; Pavlidis G; Thymis J; Birba D; Kalogeris A; Kousathana F; Kountouri A; Balampanis K; Parissis J; Andreadou I; Katogiannis K; Dimitriadis G; Bamias A; Iliodromitis E; Lambadiari V
    J Am Heart Assoc; 2020 May; 9(9):e015716. PubMed ID: 32326806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
    Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
    Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium-glucose co-transporter-2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case-control study.
    Schmedt N; Andersohn F; Walker J; Garbe E
    Diabetes Obes Metab; 2019 Jan; 21(1):52-60. PubMed ID: 30047217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprint of: Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing.
    Thompson K; Bowers BL; Evans AM
    J Am Pharm Assoc (2003); 2024; 64(4S):102177. PubMed ID: 39127942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing.
    Thompson K; Bowers BL; Evans AM
    J Am Pharm Assoc (2003); 2024; 64(3):102068. PubMed ID: 38492740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
    Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
    Heald AH; Livingston M; Bien Z; Moreno GYC; Laing I; Stedman M
    Int J Clin Pract; 2018 Apr; 72(4):e13080. PubMed ID: 29537664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA; Majumdar SR; Simpson SH; Toth EL
    Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Predictors of Metformin Prescribing in Adults with Type 2 Diabetes Mellitus: A National Cross-Sectional Study.
    Soric MM; Moorman JM; Boyle JA; Dengler-Crish CM
    Pharmacotherapy; 2016 Jul; 36(7):715-22. PubMed ID: 27208803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study.
    Pandya N; Jung M; Norfolk A; Goldblatt C; Trenery A; Sieradzan R
    J Am Med Dir Assoc; 2023 Jun; 24(6):790-797.e4. PubMed ID: 37094748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
    Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
    Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019.
    Sun JW; Hernández-Díaz S; Bourgeois FT; Haneuse S; Brill G; Bateman BT; Huybrechts KF
    Diabetes Obes Metab; 2021 Feb; 23(2):444-454. PubMed ID: 33118291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing.
    Langaas HC; Salvesen Ø; Dyrkorn R; Blix HS; Spigset O
    Scand J Prim Health Care; 2023 Sep; 41(3):224-231. PubMed ID: 37326464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.